MaxCyte Inc at Cowen Health Care Conference (Virtual) Transcript
[Welcome to the] 42nd Annual Cowen Healthcare Conference. I am Max Masucci, life science and diagnostic tools analyst at Cowen. It's my pleasure to welcome MaxCyte, a market-leading nonviral cell engineering company, a critical enabler of the cell therapy field. We are pleased to be joined by President and CEO, Doug Doerfler; and Amanda Murphy will be joining shortly. Good to see you, Doug.
Max, good to see you too. Thank you very much. Happy Monday morning.
Questions & Answers
Yes, yes, absolutely. We're off and running. Starting off with just a standard question that we're asking a lot of companies this week, including those that serve a global customer, base, are you seeing any ripple effect in the European customer base from the ongoing situation in Ukraine? Is there any exposure there, whether it's from a customer supply chain perspective?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |